Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
Clinical trial NCT00085644 · COMPLETED
Trial details
- NCT number
- NCT00085644
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2004-12-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.